Proclara Biosciences

About Proclara Biosciences

Proclara Biosciences is a clinical-stage biotechnology company based in Cambridge, MA, specializing in the development of novel therapies for neurodegenerative diseases and other conditions caused by protein misfolding. The company's unique platform targets multiple misfolded protein aggregates, which are implicated in serious diseases such as systemic amyloidoses. Proclara's business model focuses on drug development, leveraging its experienced team and collaborations with world-class advisors and partners. The company generates revenue through strategic partnerships and funding from private life sciences investors in Europe and the US. Proclara's primary clients include patients affected by neurodegenerative diseases and other protein misfolding disorders. Operating in the biotechnology market, Proclara aims to make a transformative impact on patient lives through its innovative therapeutic approaches.